Glen Harbor Capital Management’s Integra LifeSciences IART Stock Holding History

Glen Harbor Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$984K	Hold	16,388	–	–	0.02%	477
2019 Q2	$915K	Sell	16,388 -510	-3%	-$26.3K	0.02%	507
2019 Q1	$942K	Buy	16,898 +2,176	+15%	+$111K	0.02%	480
2018 Q4	$664K	Buy	14,722 +782	+6%	+$42.9K	0.02%	518
2018 Q3	$918K	Buy	13,940 +3,536	+34%	+$220K	0.02%	502
2018 Q2	$670K	Hold	10,404	–	–	0.01%	552
2018 Q1	$576K	Hold	10,404	–	–	0.01%	591
2017 Q4	$498K	Buy	10,404 +2,006	+24%	+$98.2K	0.01%	644
2017 Q3	$424K	Buy	8,398 +1,258	+18%	+$64.6K	0.01%	640
2017 Q2	$389K	Buy	7,140 +2,176	+44%	+$104K	0.01%	663
2017 Q1	$209K	Buy	4,964 +476	+11%	+$20.3K	0.01%	730
2016 Q4	$192K	Buy	+4,488	New	+$182K	0.01%	703

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Glen Harbor Capital Management's IART Position: Q3 2019 in Review

Glen Harbor Capital Management held its Integra LifeSciences (IART) position steady in Q3 2019 at 16,388 shares worth $984K. The position accounts for 0.02% of the portfolio, ranked #477.

Glen Harbor Capital Management first reported a position in IART in Q4 2016 and has held it in 12 quarters since. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Glen Harbor Capital Management held 16,388 shares of Integra LifeSciences worth $984K as of Q3 2019.
Glen Harbor Capital Management left its Integra LifeSciences share count unchanged in Q3 2019.
Integra LifeSciences made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #477 holding.
Glen Harbor Capital Management first reported a position in Integra LifeSciences in Q4 2016 and has held it in 12 quarters since.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.